2012
DOI: 10.1128/cvi.00174-12
|View full text |Cite
|
Sign up to set email alerts
|

Structural and Immunological Analysis of Anthrax Recombinant Protective Antigen Adsorbed to Aluminum Hydroxide Adjuvant

Abstract: ABSTRACTNew anthrax vaccines currently under development are based on recombinant protective antigen (rPA) and formulated with aluminum adjuvant. Because long-term stability is a desired characteristic of these vaccines, an understanding of the effects of adsorption to aluminum adjuvants on the structure of rPA is important. Using both biophysical and immunological techniques, we compared the structure and immunogenicity of freshly prepared rPA-Alhydrogel formulations to that o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
36
0
1

Year Published

2013
2013
2015
2015

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(38 citation statements)
references
References 41 publications
1
36
0
1
Order By: Relevance
“…As shown in Fig. 6, the wild-type rPA-Alhydrogel formulation exhibited a significant decrease in immunogenicity over time (P Ͻ 0.05; ANOVA with Tukey posttest for trend) as has been reported previously (28). In contrast, the immunogenicity of the six-Asp mutant rPA-Alhydrogel formulation did not change significantly upon storage.…”
Section: Resultsmentioning
confidence: 59%
See 1 more Smart Citation
“…As shown in Fig. 6, the wild-type rPA-Alhydrogel formulation exhibited a significant decrease in immunogenicity over time (P Ͻ 0.05; ANOVA with Tukey posttest for trend) as has been reported previously (28). In contrast, the immunogenicity of the six-Asp mutant rPA-Alhydrogel formulation did not change significantly upon storage.…”
Section: Resultsmentioning
confidence: 59%
“…This irreversible binding interferes with methodologies that could be used to assess deamidation. Factors other than deamidation, such as structural destabilization of rPA protein upon adsorption to aluminum adjuvant (28), may have contributed to the loss of immunogenicity that we observed with the wild-type rPA formulation. Of note, however, is the observation that after 4 weeks of storage, the wild-type rPA and sixAsp mutant vaccine formulations exhibited similar immunogenicities, consistent with the idea that deamidation of susceptible Asn residues played a role in the loss of immunogenicity seen over time with the wild-type rPA formulation.…”
Section: Discussionmentioning
confidence: 57%
“…Indeed, in our experiments the antigen was completely adsorbed immediately after mixing with the adjuvant (data not shown). Previous studies have revealed that the interaction with aluminum hydroxide, which strongly depends on the properties of the antigen, buffer composition, pH, and physicochemical properties of the aluminum preparation used, can affect the structure of protein immunogens (15)(16)(17)(18). Flavivirus particles are probably especially prone to adsorption-related structural effects, since the organization of their E proteins in the viral membrane is subject to dynamic changes (29,30,67), can be fixed in different configurations (e.g., by the interaction with specific antibodies [67]), and can undergo extensive temperaturedependent rearrangements (29,30,67).…”
Section: Discussionmentioning
confidence: 99%
“…In the case of protein antigens, this interaction can lead to changes in the secondary or tertiary structure and can affect protein stability (15)(16)(17)(18). Since adsorption-induced effects on protein structure can potentially modulate the fine specificities and, consequently, the functional activities of antibodies elicited by immunization, such changes can affect the effectiveness of vaccination.…”
mentioning
confidence: 99%
“…For example, as is evident in phase 1 clinical trials, rPA vaccines do not address the need for an improved dosing schedule over the current vaccine, AVA, and induce equivalent levels, at best, of toxin neutralizing antibodies. In addition, rPA adsorbed to aluminum hydroxide adjuvant has been shown to lose its ability to induce toxin neutralizing antibodies as it is stored 47,48 . For obvious reasons, long-term stability is an important characteristic of a stock-piled vaccine.…”
Section: Experimental Anthrax Vaccinesmentioning
confidence: 99%